60 related articles for article (PubMed ID: 1470565)
1. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
Wiśniewska RJ; Kupryszewski G
Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
5. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
6. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
[TBL] [Abstract][Full Text] [Related]
7. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart.
Wiśniewska R; Wiśniewski K
Rocz Akad Med Bialymst; 1996; 41(2):183-90. PubMed ID: 9020529
[TBL] [Abstract][Full Text] [Related]
8. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats.
Wiśniewska RJ; Wiśniewski K
Gen Pharmacol; 1996 Jan; 27(1):159-63. PubMed ID: 8742514
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
Fekete M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
Crawley JN; St-Pierre S; Gaudreau P
J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
[TBL] [Abstract][Full Text] [Related]
11. Effects of cholecystokinin octapeptide on rat cardiac function and the receptor mechanism.
Zhao XY; Ling YL; Meng AH; Shan BE; Zhang JL
Sheng Li Xue Bao; 2002 Jun; 54(3):239-43. PubMed ID: 12075472
[TBL] [Abstract][Full Text] [Related]
12. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat.
Gillis RA; Quest JA; Pagani FD; Souza JD; Da Silva AM; Jensen RT; Garvey TQ; Hamosh P
J Pharmacol Exp Ther; 1983 Feb; 224(2):408-14. PubMed ID: 6296361
[TBL] [Abstract][Full Text] [Related]
13. [Cholecystokinin-octapeptide antagonizes the central depressive effect of opioid peptides in rats].
Mei L; Han JS
Sheng Li Xue Bao; 1991 Apr; 43(2):156-63. PubMed ID: 2068585
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
15. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholecystokinin, caerulein and pentagastrin on arterial blood pressure and plasma renin activity in rats.
Wiśniewska RJ
Pol J Pharmacol; 1997; 49(6):419-23. PubMed ID: 9566045
[TBL] [Abstract][Full Text] [Related]
17. [The immunostimulating properties of cholecystokinin octapeptide and its fragments].
Molchanova IV; Belokrylov GA; Popova OIa; Kalikhevich VN
Biull Eksp Biol Med; 1992 Dec; 114(12):631-3. PubMed ID: 1292696
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin (CCK) and C-terminal fragments of CCK: effects of CCK-33, CCK-8 and CCK-4 in the cardiovascular system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Gen Pharmacol; 1996 Mar; 27(2):399-405. PubMed ID: 8919664
[TBL] [Abstract][Full Text] [Related]
19. [Cholecystokinin octapeptide antagonized the effect of NDAP on CaM in rat dorsal spinal synaptosome].
Chen SZ; Han JS
Sheng Li Xue Bao; 1994 Apr; 46(2):120-5. PubMed ID: 7973792
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
